Skyline Urology is acquiring Exact Imaging's ExactVu micro-ultrasound system for real-time targeted prostate biopsies in California.
Skyline Urology chief medical officer Richard D. David said: “At Skyline Urology, we are dedicated to providing the highest level of patient care, and investments in the newest imaging technologies to allow our physicians to achieve these outcomes is essential.
“Our acquisition of this ExactVu high resolution micro-ultrasound system will allow our urologists to actually visualize suspicious regions, and then target their prostate biopsies in real-time.
“Skyline patients will benefit from this excellent new platform that will allow us to ultimately improve our biopsies with the end goal of allowing our physicians to more accurately diagnose significant prostate cancer.”
David continued saying: “The ExactVu micro-ultrasound system is a paradigm shift in real-time imaging striving to get even more accurate biopsies using the highest resolution modalities to enable the fastest, most detailed imaging of the prostate. With the system’s FusionVu feature, we can also align the patient’s prostate MRI with the live micro-ultrasound image to either perform Cognitive Assist or micro-ultrasound/MRI fusion-guided biopsies, all with the benefit of the 70-micron resolution of micro-ultrasound. This allows us to see lesions that were unseen with our older technologies.”
Exact Imaging president and CEO Randy AuCoin said: “We are thrilled to have Skyline Urology as the first practice in California to adopt our ExactVu micro-ultrasound platform.
“The ExactVu micro-ultrasound system provides the highest real-time resolution for targeted prostate biopsies and through this progressive urology practice, patients in California can now have access to micro-ultrasound for their prostate biopsies.”
The ExactVu customer base is growing globally as the urological community is recognizing the power of micro-ultrasound for providing excellent resolution for visualizing the prostate and providing real-time targeted guidance of prostate biopsies in a manner that is fast, cost-effective, and convenient for the patient.
Source: Company Press Release